Equities

Arch Therapeutics Inc

ARTH:QBB

Arch Therapeutics Inc

Actions
  • Price (USD)0.51
  • Today's Change-0.021 / -3.91%
  • Shares traded240.00
  • 1 Year change-73.85%
  • Beta3.5683
Data delayed at least 15 minutes, as of Sep 20 2024 20:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Arch Therapeutics Inc share price to rise to 600.00 in the next year from the last price of 0.51.
High117,547.1%600.00
Med117,547.1%600.00
Low117,547.1%600.00

Earnings history & estimates in USD

Earnings forecasts are not available for Arch Therapeutics Inc. On Aug 19, 2024, Arch Therapeutics Inc reported 3rd quarter 2024 losses of -- per share.
Arch Therapeutics Inc reported annual 2023 losses of -2.27 per share on Feb 15, 2024.
Average growth rate+14.98%
More ▼

Revenue history & estimates in USD

Revenue forecasts are not available for Arch Therapeutics, Inc..
Arch Therapeutics, Inc. had revenues for the full year 2023 of 76.00k. This was 375.00% above the prior year's results.
Average growth rate+136.11%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.